Search results for "RC666-701"

showing 10 items of 122 documents

Real-World Data of Anticoagulant Treatment in Non-valvular Atrial Fibrillation

2022

AimsTo assess the impact of anticoagulant treatment on risk for stroke and all-cause mortality of patients with atrial fibrillation using real-world data (RWD).MethodsPatients with prevalent or incident atrial fibrillation were selected throughout a study period of 5 years. Stroke, transitory ischemic attack, hemorrhagic stroke, and all-cause mortality were identified in the claims of the electronic health records (EHRs). Subjects were classified according to the anticoagulant treatment in four groups: untreated, vitamin K antagonists (VKAs), New Oral Anticoagulants (NOACs), and antiplatelet (AP). Risk of events and protection with anticoagulant therapy were calculated by Cox proportional h…

anticoagulant therapyRC666-701VKADiseases of the circulatory (Cardiovascular) systematrial fibrillationNOACsCardiovascular MedicineantiplateletCardiology and Cardiovascular MedicinestrokemortalityOriginal ResearchFrontiers in Cardiovascular Medicine
researchProduct

Aortic Stiffness in HIV Infection with and without Antiretroviral Therapy. A Meta-analysis of Observational Studies

2020

Background: The risk of Cardiovascular (CV) events is higher in HIV-infected patients (HIV+) compared to HIV-uninfected persons (HIV−). Large artery stiffness, a well-documented predictor of adverse CV prognosis, may mediate this enhanced risk. It is usually assessed by measuring aortic Pulse Wave Velocity (aPWV). Studies examining arterial stiffness in HIV+ yielded inconsistent results. We performed a meta-analysis with the aim to evaluate the association of HIV infection and its therapy [Antiretroviral Therapy (ART)] with aPWV. Design and Method: The Standardized Mean Difference (SMD) and corresponding 95% confidence intervals were calculated for aPWV in different comparison groups. Stati…

cardiovascular riskmedicine.medical_specialtySettore MED/09 - Medicina Internaaortic stiffnessSettore MED/17 - Malattie Infettivebusiness.industrypulse wave velocityHIV infection cardiovascular risk pulse wave velocity aortic stiffnessHuman immunodeficiency virus (HIV)virus diseasesSpecialties of internal medicineGeneral Medicinemedicine.disease_causeHIV infectionAntiretroviral therapyRC581-951Meta-analysisInternal medicineRC666-701MedicineDiseases of the circulatory (Cardiovascular) systemObservational studyAortic stiffnessbusinessPulse wave velocityArtery Research
researchProduct

Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel

2021

Efforts in the fight against COVID-19 are achieving success in many parts of the world, although progress remains slow in other regions. We believe that a syndemic approach needs to be adopted to address this pandemic given the strong apparent interplay between COVID-19, its related complications, and the socio-structural environment. We have assembled an international, multidisciplinary group of researchers and clinical practitioners to promote a novel syndemic approach to COVID-19: the CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). This geographically diverse group aims to facilitate collaborative-networking and scientific exchanges between researchers and …

diabetescomplicationsRC666-701pandemicPerspectivesyndemicDiseases of the circulatory (Cardiovascular) systemCOVID-19Cardiovascular MedicineCardiology and Cardiovascular Medicinecardiovascular diseasesFrontiers in Cardiovascular Medicine
researchProduct

Hemodynamic Changes During Physiological and Pharmacological Stress Testing in Healthy Subjects, Aortic Stenosis and Aortic Coarctation Patients–A Sy…

2019

Introduction: Exercise testing has become a diagnostic standard in the evaluation and management of heart disease. While different methods of exercise and pharmacological stress testing exist, only little is known about their comparability. We aimed to assess hemodynamic changes during dynamic exercise, isometric exercise, and dobutamine stress testing at different stress intensities in healthy subjects and patients with aortic stenosis (AS) and aortic coarctation (CoA).Methods: A systematic literature search (PROSPERO 2017:CRD42017078608) in MEDLINE of interventional trials was conducted to identify eligible studies providing evidence of changes in hemodynamic parameters under different st…

exercise testinglcsh:Diseases of the circulatory (Cardiovascular) systemdobutamine stresslcsh:RC666-701healthy subjectsaortic stenosishemodynamicsaortic coarctationFrontiers in Cardiovascular Medicine
researchProduct

Sex-Specific Relationship Between Parathyroid Hormone and Platelet Indices in Phenotypes of Heart Failure—Results From the MyoVasc Study

2021

Background: Heart failure (HF) is a multifactorial syndrome with pathophysiological complexities still not fully understood. Higher mean platelet volume (MPV), a potential marker of platelet activation, and high concentrations of parathyroid hormone (PTH) have been implicated in the pathogenesis of HF.Aim: This study aims to investigate sex-specifically the association between PTH concentrations and platelet indices in phenotypes of HF.Methods and Results: PTH and platelet indices (MPV and platelet count) were available in 1,896 participants from the MyoVasc study in Mainz, Germany. Multivariable linear regression models, adjusted for age, sex, season, vitamin D status, cardiovascular risk …

heart failure with preserved ejection fractionBIOMARKERmedicine.medical_specialtyPATHOPHYSIOLOGYheart failureParathyroid hormoneCardiovascular Medicine030204 cardiovascular system & hematologyMPVDISEASE03 medical and health sciences0302 clinical medicineInternal medicineMANAGEMENTVitamin D and neurologymedicineDiseases of the circulatory (Cardiovascular) systemparathyroid hormoneheart failure with reduced ejection fractionPlatelet030212 general & internal medicinePlatelet activationMean platelet volumeVITAMIN-DOriginal ResearchRISKEjection fractionbusiness.industryMORTALITYplatelet countmedicine.diseaseDYSFUNCTIONEndocrinologyRC666-701Heart failureCardiology and Cardiovascular MedicineHeart failure with preserved ejection fractionbusinessFrontiers in Cardiovascular Medicine
researchProduct

Healthy mitochondria for stroke cells.

2018

Stroke is a debilitating disease that remains as a significant unmet need. Although our understanding of the disease pathology has advanced over the years, treatment options for stroke are limited. Recent studies have implicated the important role of healthy mitochondria in neuroprotection against stroke. Under the stroke pathological condition, transfer of healthy mitochondria is observed from astrocytes to ischemic neurons. However, without additional therapeutic intervention, such astrocyte-to-neuron transfer of mitochondria may not sufficiently afford a robust and stable therapeutic effect against the devastating primary insult and progressive neurodegeneration associated with stroke. W…

lcsh:Diseases of the circulatory (Cardiovascular) systemAginglcsh:Medical technologyneuronsReview ArticleDiseaseMitochondrion010402 general chemistryBioinformatics01 natural sciencesNeuroprotectionstem cellsmedicineStrokePathological010405 organic chemistrybusiness.industryNeurosciencesGeneral Medicinemedicine.diseaseStem Cell Researchstrokeneuronendothelial cells0104 chemical sciencesReview articleBrain Disordersstem cellTransplantationmitochondriaStrokelcsh:R855-855.5lcsh:RC666-701AstrocytesNeurologicalendothelial cellStem cellAstrocytebusiness
researchProduct

Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diab…

2017

Aims These recommendations aim to improve care for patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk in Central and Eastern Europe. Cardiovascular disease (CVD) and/or chronic kidney disease (CKD) are major interdependent comorbidities in patients with T2D, accounting for 50% of mortality. Following recent CV outcomes trial (CVOT) results, including those from EMPA-REG OUTCOME®, LEADER®, SUSTAIN™-6 and, most recently, the CANVAS study, it is essential to develop regional expert consensus recommendations to aid physicians in interpreting these newest data to clinical practice. Methods The Central and Eastern European Diabetes Expert Group (CEEDEG) followed a Delphi method …

lcsh:Diseases of the circulatory (Cardiovascular) systemKeywords: Anti-glycaemic drugs ; Cardiovascular disease ; Renal disease ; Type 2 diabetesmedicine.medical_specialtyEndocrinology Diabetes and Metabolism10265 Clinic for Endocrinology and DiabetologyDelphi method610 Medicine & health030209 endocrinology & metabolismReviewType 2 diabetesDisease030204 cardiovascular system & hematologyAnti-glycaemic drugs2705 Cardiology and Cardiovascular MedicineTranslational Research BiomedicalRenal disease03 medical and health sciences0302 clinical medicineMultidisciplinary approachDiabetes mellitusDiabetes MellitusmedicineHumansHypoglycemic AgentsEurope EasternIntensive care medicineExpert TestimonyClinical Trials as Topicbusiness.industryType 2 diabetesCardiovascular diseasemedicine.diseaseExpert groupEuropeEastern european2712 Endocrinology Diabetes and MetabolismTreatment Outcome2724 Internal MedicineCardiovascular Diseaseslcsh:RC666-701Practice Guidelines as TopicCardiology and Cardiovascular MedicinebusinessKidney diseaseCardiovascular Diabetology
researchProduct

Advancing stem cells: New therapeutic strategies for treating central nervous system disorders

2018

In this special issue, we explore new methods and knowledge to improve stem cell transplantation in diseases and conditions such as stroke, PD, and depression. Advancing the conventional idea regarding cell replacement in stem cell therapy, stem cells may also transfer healthy mitochondria to diseased ischemic neurons in stroke and improve the therapeutic time window of tissue plasminogen activator (tPA) in a conjunctive therapy for stroke, and human Wharton’s Jelly-derived mesenchymal stromal cells (hWJ-MSCs) may rely mainly on trophic factor secretion to induce neuroprotective effects. In addition, trophic factors such as neurotrophin-4/5 (NT-4/5) and glial cell line-derived neurotrophic …

lcsh:Diseases of the circulatory (Cardiovascular) systemParkinson's diseaselcsh:Medical technologyCentral nervous systemBioinformaticsTissue plasminogen activatorParkinson’s DiseaseWharton’s Jelly‑derived Mesenchymal Stromal CellText miningMitochondrial TargetingmedicineGlial cell line-derived neurotrophic factorStrokeDepression (differential diagnoses)biologybusiness.industryDepressionGeneral Medicinemedicine.diseaseGDNFStrokemedicine.anatomical_structureEditoriallcsh:R855-855.5lcsh:RC666-701White Matter RepairTissue Plasminogen Activatorbiology.proteinsuperparamagnetic iron oxideStem cellbusinessCosmic Radiationmedicine.drug
researchProduct

Fabry Disease, a Complex Pathology Not Easy to Diagnose

2015

Fabry disease is a multisystemic lysosomal storage disorder, inherited in an X-linked manner. It is a defect of metabolism of the glycosphingolipids, due to the reduction or absence of the activity of lysosomal enzyme α-galactosidase A. This reduction of activity causes the storage of globotriaosylceramide and derivatives in the lysosomes, triggering a cascade of cellular events, mainly in vascular endothelium. These events are the responsible for the systemic clinical manifestations and the renal, cardiac and cerebrovascular complications, or a combination of them. The symptomatology can lead to the premature death of patient between the fourth or fifth decade of life. The first symptoms c…

lcsh:Diseases of the circulatory (Cardiovascular) systemPathologymedicine.medical_specialtyα-galactosidase Abusiness.industryGlobotriaosylceramideDiagnostic testDiseaseEnzyme replacement therapyAnderson-Fabry diseasemedicine.diseaseFabry diseaseVascular endotheliumchemistry.chemical_compoundPremature deathchemistrylcsh:RC666-701Clinical diagnosismedicineGeneral Earth and Planetary SciencesbusinessGLA gene.General Environmental ScienceCardiogenetics
researchProduct

A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report

2012

Abstract Background Fabry disease (FD) is a hereditary metabolic disorder caused by the partial or total inactivation of a lysosomal hydrolase, the enzyme α-galactosidase A (GLA). This inactivation is responsible for the storage of undegraded glycosphingolipids in the lysosomes with subsequent cellular and microvascular dysfunction. The incidence of disease is estimated at 1:40,000 in the general population, although neonatal screening initiatives have found an unexpectedly high prevalence of genetic alterations, up to 1:3,100, in newborns in Italy, and have identified a surprisingly high frequency of newborn males with genetic alterations (about 1:1,500) in Taiwan. Case presentation We des…

lcsh:Diseases of the circulatory (Cardiovascular) systemPathologyα-galactosidase AAnderson-Fabry mutationBiopsyDNA Mutational AnalysisCase Reportmedicine.disease_causeGlobotriaosylceramide0302 clinical medicineSettore BIO/13 - Biologia ApplicataPromoter Regions Genetic0303 health sciencesMutationeducation.field_of_studymedicine.diagnostic_testbiologyMetabolic disorderMagnetic Resonance Imaging3. Good healthPhenotypeCardiovascular DiseasesDisease ProgressionFemaleKidney DiseasesRenal biopsyCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyPopulation03 medical and health sciencesPredictive Value of TestsBiopsymedicineHumansHigh resolution meltingGenetic Predisposition to Diseaseeducation030304 developmental biologyFabry diseaseAlpha-galactosidasebusiness.industrymedicine.diseaseFabry diseaseIntronslcsh:RC666-701alpha-GalactosidaseMutationGLAbiology.proteinbusiness030217 neurology & neurosurgeryKidney disease
researchProduct